Duloxetine Capsules Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 20 mg, 30 mg, 40 mg, 60 mg
Reference Brands: Cymbalta®(US & EU)
Category:
Antipsychotropic Drugs
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases levels of these neurotransmitters in the brain to improve mood and relieve pain. It is used to treat major depressive disorder, generalized anxiety disorder, diabetic neuropathy, fibromyalgia, and chronic musculoskeletal pain, offering both mood stabilization and pain management benefits.
Duloxetine Capsules is available in Capsules
and strengths such as 20 mg, 30 mg, 40 mg, 60 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Duloxetine Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Duloxetine Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Duloxetine capsules are approved by the FDA in the USA for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. In the EU, duloxetine is authorized under brand names like Cymbalta for similar indications. It is a prescription-only serotonin-norepinephrine reuptake inhibitor (SNRI) and requires liver function monitoring due to potential hepatotoxicity. Regulatory authorities in both regions emphasize patient safety through risk minimization and pharmacovigilance programs. To explore different forms, approved manufacturers, and compliant sourcing of Duloxetine Capsules, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing